Back to Agenda
S39 : Innovative Thinking to Optimize Drug Development for Rare Diseases - Ideas for Efficacy Evaluation and Strategies for Utilizing RWD -
Session Chair(s)
Kazuo Nakamura, PHD
Representative Director, Chairman and CEO, CMIC HOLDINGS, Japan
Speaker(s)
Kiichiro Toyoizumi
Associate Director, Statistics & Decision Sciences Department, Janssen Pharmaceutical K.K, Japan
Lovisa Berggren
Professor, Department of Neurology, UCB S.A., Germany
Kazumasa Tanzawa
, St. Marianna University School of Medicine, Japan
Yasuhiro Araki, PHD
Director, Office of Clinical Trial Promotion, Health Policy Bureau, Ministry of Health, Labour and Welfare (MHLW), Japan
Osamu Komiyama
Senior Manager, Statistical Research & Data Science, Pfizer R&D Japan G.K., Japan
Have an account?